Thursday - December 26, 2024

Pyrido [2,3-D]pyrimidine Derivatives as Inhibitors of Human Immunodeficiency Virus Replication

2024-10-29

ALEXANDRIA, Virginia, Oct. 29 -- VIIV HEALTHCARE UK (NO. 5) LIMITED, Stevenage, United Kingdom has been assigned a patent (No. US 12129255 B2, initially filed June 17, 2020) developed by Eric P. Gillis, Branford, Connecticut, and Christiana Iwuagwu, Wallingford, Connecticut, for "Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Pyrido [2,3-D]pyrimidine Derivatives as Inhibitors of Human Immunodeficiency Virus Replication

Information Request Form

Copyright Targeted News Service 2024